The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/Ib study with INT-1B3, a novel LNP-formulated micro-RNA (miR-193a-3p mimic) therapeutic for patients with advanced solid cancer.
 
Nuria Kotecki
No Relationships to Disclose
 
Frans Opdam
No Relationships to Disclose
 
Debbie Robbrecht
Honoraria - Springer
Consulting or Advisory Role - Cantargia AB; Faron Pharmaceuticals; Servier (Inst)
 
Michiel Strijbos
No Relationships to Disclose
 
Karlijn Kroon
Employment - Bexon Clinical Consulting; InteRNA; Merus NV
Consulting or Advisory Role - Bexon Clinical Consulting; InteRNA; Merus NV
 
Michel Janicot
Leadership - InteRNA
Stock and Other Ownership Interests - InteRNA
Consulting or Advisory Role - ElmediX; InteRNA; Oncoheroes Biosciences
Travel, Accommodations, Expenses - InteRNA; Oncoheroes Biosciences
 
Sanaz Yahyanejad
Honoraria - InteRNA
 
Bryony Telford
Employment - InteRNA
Honoraria - InteRNA
 
Marion van den Bosch
Honoraria - InteRNA
 
Farshid Alemdehy
Honoraria - InteRNA
 
Thijs de Gunst
Honoraria - InteRNA
 
Harm den Boer
Honoraria - InteRNA
 
Rogier M. Vos
Honoraria - InteRNA
 
Laurens van Pinxteren
Honoraria - InteRNA
 
Roel Schaapveld
Employment - InteRNA
Leadership - InteRNA
Stock and Other Ownership Interests - InteRNA
Honoraria - InteRNA
Patents, Royalties, Other Intellectual Property - InteRNA